TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients. [electronic resource]
- Hellenic journal of nuclear medicine
- 146-50 p. digital
Publication Type: Clinical Trial; Journal Article
1790-5427
Adolescent Adult Aged Female Graves Disease Humans Immunoglobulins, Thyroid-Stimulating Male Middle Aged Prognosis Radiopharmaceuticals Remission Induction Reproducibility of Results Sensitivity and Specificity Technetium Thyrotropin--therapeutic use Treatment Outcome Young Adult